Biomarkers, designs, and interpretations of resting‐state fMRI in translational pharmacological research: A review of state‐of‐the‐Art, challenges, and opportunities for …

N Khalili‐Mahani, SARB Rombouts… - Human brain …, 2017 - Wiley Online Library
A decade of research and development in resting‐state functional MRI (RSfMRI) has
opened new translational and clinical research frontiers. This review aims to bridge between …

[HTML][HTML] The role of fMRI in drug development

O Carmichael, AJ Schwarz, CH Chatham, D Scott… - Drug discovery today, 2018 - Elsevier
Highlights•Functional MRI continues to have the potential to play a useful role in developing
novel compounds.•But the lack of consensus on optimal techniques for acquisition and …

Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate

D Downey, A Dutta, S McKie, GR Dawson… - European …, 2016 - Elsevier
Intravenous infusion of lanicemine (formerly AZD6765), a low trapping non-selective N-
methyl-D-aspartate (NMDA) receptor antagonist, induces antidepressant effects with a …

[HTML][HTML] Multivariate and repeated measures (MRM): A new toolbox for dependent and multimodal group-level neuroimaging data

M McFarquhar, S McKie, R Emsley, J Suckling, R Elliott… - Neuroimage, 2016 - Elsevier
Repeated measurements and multimodal data are common in neuroimaging research.
Despite this, conventional approaches to group level analysis ignore these repeated …

The origins of '5-HT and mechanisms of defence'by Deakin and Graeff: a personal perspective

JFW Deakin - Journal of psychopharmacology, 2013 - journals.sagepub.com
In this brief reflection I outline how Fred Graeff and I came to integrate our ideas and findings
concerning the behavioural functions of serotonin (5-HT) over 20 years ago in '5-HT and …

Use of functional imaging across clinical phases in CNS drug development

D Borsook, L Becerra, M Fava - Translational psychiatry, 2013 - nature.com
The use of novel brain biomarkers using nuclear magnetic resonance imaging holds
potential of making central nervous system (CNS) drug development more efficient. By …

[HTML][HTML] Mapping glucose-mediated gut-to-brain signalling pathways in humans

TJ Little, S McKie, RB Jones, M D'Amato, C Smith… - Neuroimage, 2014 - Elsevier
Objectives Previous fMRI studies have demonstrated that glucose decreases the
hypothalamic BOLD response in humans. However, the mechanisms underlying the CNS …

Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects

L Becerra, J Upadhyay, PC Chang, J Bishop… - … of Pharmacology and …, 2013 - ASPET
Pharmacological magnetic resonance imaging (phMRI) is one method by which a drug's
pharmacodynamic effects in the brain can be assessed. Although phMRI has been …

Central functional response to the novel peptide cannabinoid, hemopressin

GT Dodd, AA Worth, DJ Hodkinson, RK Srivastava… - …, 2013 - Elsevier
Hemopressin is the first peptide ligand to be described for the CB1 cannabinoid receptor.
Hemopressin acts as an inverse agonist in vivo and can cross the blood–brain barrier to …

Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI

CS Symonds, S McKie, R Elliott, JFW Deakin… - European …, 2012 - Elsevier
Impaired hippocampal function is believed to be important in the pathogenesis of
depression. The hippocampus contains a high concentration of both mineralocorticoid (MR) …